GAMMA Investing’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.15K | Buy |
295
+28
| +10% | +$489 | ﹤0.01% | 3104 |
|
|
2025
Q1 | $3.36K | Buy |
267
+191
| +251% | +$2.4K | ﹤0.01% | 3236 |
|
|
2024
Q4 | $802 | Sell |
76
-31
| -29% | -$327 | ﹤0.01% | 3476 |
|
|
2024
Q3 | $1.55K | Buy |
107
+31
| +41% | +$450 | ﹤0.01% | 3140 |
|
|
2024
Q2 | $647 | Sell |
76
-24
| -24% | -$204 | ﹤0.01% | 3155 |
|
|
2024
Q1 | $1.02K | Buy |
100
+24
| +32% | +$245 | ﹤0.01% | 2937 |
|
|
2023
Q4 | $472 | Buy |
+76
| New | +$472 | ﹤0.01% | 2980 |
|